NeuroPace (NASDAQ:NPCE) and ADM Tronics Unlimited (OTCMKTS:ADMT) Head-To-Head Analysis

NeuroPace (NASDAQ:NPCE) and ADM Tronics Unlimited (OTCMKTS:ADMT) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their valuation, earnings, profitability, analyst recommendations, risk, institutional ownership and dividends.

Volatility & Risk

NeuroPace has a beta of 1.92, indicating that its share price is 92% more volatile than the S&P 500. Comparatively, ADM Tronics Unlimited has a beta of 0.16, indicating that its share price is 84% less volatile than the S&P 500.

Insider & Institutional Ownership

78.8% of NeuroPace shares are held by institutional investors. 20.5% of NeuroPace shares are held by company insiders. Comparatively, 73.0% of ADM Tronics Unlimited shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Profitability

This table compares NeuroPace and ADM Tronics Unlimited’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
NeuroPace	-21.47%	-105.67%	-20.01%
ADM Tronics Unlimited	-0.20%	-0.85%	-0.32%

Earnings & Valuation

This table compares NeuroPace and ADM Tronics Unlimited”s gross revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
NeuroPace	$99.99 million	5.80	-$21.47 million	($0.66)	-25.86
ADM Tronics Unlimited	$3.20 million	1.76	-$120,000.00	N/A	N/A

ADM Tronics Unlimited has lower revenue, but higher earnings than NeuroPace.

Analyst Ratings

This is a breakdown of current ratings for NeuroPace and ADM Tronics Unlimited, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
NeuroPace	1	1	4	2	2.88
ADM Tronics Unlimited	0	0	0	0	0.00

NeuroPace currently has a consensus price target of $18.67, suggesting a potential upside of 9.35%. Given NeuroPace’s stronger consensus rating and higher probable upside, equities analysts plainly believe NeuroPace is more favorable than ADM Tronics Unlimited.

Summary

NeuroPace beats ADM Tronics Unlimited on 8 of the 13 factors compared between the two stocks.

About NeuroPace

NeuroPace, Inc. operates as a medical device company in the United States. The company develops RNS system, a brain-responsive neuromodulation system that delivers personalized, real-time treatment at the seizure source for treating medically refractory focal epilepsy. It also records continuous brain activity data and enables clinicians to monitor patients in person and remotely. Its RNS System includes RNS neurostimulator, cortical strip and depth leads, and Patient Remote Monitor, as well as other implantable and non-implantable accessories. The company sells its products to hospital facilities for initial RNS system implant procedures and for replacement procedures. NeuroPace, Inc. was incorporated in 1997 and is headquartered in Mountain View, California.

About ADM Tronics Unlimited

ADM Tronics Unlimited, Inc., through its subsidiaries, develops, manufactures, and sells electronics for non-invasive medical and other applications in the United States, Australia, Asia, and Europe. It operates through Chemical, Electronics, and Engineering segments. The company offers proprietary devices for use in diagnostics and therapeutics of humans and animals; and electronic controllers for spas and hot tubs. In addition, the company provides water-based primers and adhesives; water-based coatings and resins; water-based chemical additives; and anti-static conductive paints, coatings, and other products. Further, it offers water-based, adhesive and related topical formulations for use in maxillofacial prosthetic medical applications; and for professional makeup applications primarily for film, TV, and theatrical productions. Additionally, the company provides research, development, regulatory, and engineering services for the design, development, and manufacturing of medical devices, electronics, and other technologies and products, as well as medical electronic therapeutic technology. ADM Tronics Unlimited, Inc. was incorporated in 1969 and is headquartered in Northvale, New Jersey.